Heterozygous pathogenic variants in GLI1 are a common finding in isolated postaxial polydactyly A/B.

Data de publicació: Data Ahead of Print:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Palencia-Campos A
  • Martínez-Fernández ML
  • Altunoglu U
  • Soto-Bielicka P
  • Torres A
  • Sentürk L
  • Berköz Ö
  • Yildiran M
  • Kayserili H
  • Gil-Camarero E
  • Colli-Lista G
  • Sanchís-Calvo A
  • ECEMC Working Group on Polydactyly
  • Guillén-Navarro E
  • López-González V
  • Ballesta-Martínez M
  • Rosell J
  • Aglan MS
  • Temtamy S
  • Otaify GA
  • Cuevas-Catalina L
  • Torres-Saavedra MN
  • Nevado J
  • Tenorio J
  • Lapunzina P
  • Bermejo-Sánchez E
  • Ruiz-Pérez VL

Grups d'Investigació

Abstract

Postaxial polydactyly (PAP) is a frequent limb malformation consisting in the duplication of the fifth digit of the hand or foot. Morphologically, this condition is divided into type A and B, with PAP-B corresponding to a more rudimentary extra-digit. Recently, bi-allelic truncating variants in the transcription factor GLI1 were reported to be associated with a recessive disorder, which in addition to PAP-A, may include syndromic features. Moreover, two heterozygous subjects carrying only one inactive copy of GLI1 were also identified with PAP. Herein, we aimed to determine the level of involvement of GLI1 in isolated PAP, a condition previously established to be autosomal dominantly inherited with incomplete penetrance. We analysed the coding region of GLI1 in 95 independent probands with non-syndromic PAP and found 11.57% of these subjects with single heterozygous pathogenic variants in this gene. The detected variants lead to premature termination codons or result in amino acid changes in the DNA-binding domain of GLI1 that diminish its transactivation activity. Family segregation analysis of these variants was consistent with dominant inheritance with incomplete penetrance. We conclude that heterozygous changes in GLI1 underlie a significant proportion of sporadic or familial cases of isolated PAP-A/B. This article is protected by copyright. All rights reserved.

Dades de la publicació

ISSN/ISSNe:
1059-7794, 1098-1004

HUMAN MUTATION  WILEY

Tipus:
Article
Pàgines:
265-276
PubMed:
31549748
Factor d'Impacte:
1,981 SCImago
Quartil:
Q1 SCImago

Cites Rebudes en Web of Science: 5

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • GLI1, Postaxial polydactyly A/B, hedgehog signaling, incomplete penetrance, limb development

Projectes associats

CARACTERIZACION MOLECULAR DE PACIENTES CON SINDROME DE USHER. ESTUDIO DE LOS GENES RESPONSABLES: CDH23 Y PCDH15 Y CANDIDATOS: WHRN, CXADR Y PDZK7

Investigador Principal: JOSÉ MARÍA MILLÁN SALVADOR

PI07/0558 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2008

TRANSLATIONAL RESEARCH, EXPERIMENTAL MEDICINE AND THERAPEUTICS ON CHARCOT-MARIE-TOOTH. TREAT-CMT

Investigador Principal: JOSÉ MARÍA MILLÁN SALVADOR

TREAT-CMT . CIBER ENFERMEDADES RARAS; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012

IDENTIFICACIÓN DE NUEVOS GENES Y MECANISMOS MOLECULARES EN EL SÍNDROME DE USHER Y SU TRASLACIÓN AL DIAGNÓSTICO.

Investigador Principal: JOSÉ MARÍA MILLÁN SALVADOR

PI13/00638 . INSTITUTO DE SALUD CARLOS III . 2014

COMPREHENSIVE, INTEGRATIVE AND GENOMIC APPROACH TO THE UNDERSTANDING AND TREATMENT OF CANCER AND LEUKEMIA.

Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO

PIE13/00046 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014

THERAPEUTIC APPROACHES FOR RETINITIS PIGMENTOSA AND USHER SYNDROME BASED ON GENOME-EDICTING BY CRISPR/CAS9.

2014/0273_CRC_ALLER_TODOS_SOMOS_RAROS . 2015

SEGUIMIENTO DE PACIENTES SOMETIDOS A TRASPLANTE CARDIACO. ESTUDIO DE MARCADORES DE RECHAZO IMPLICADOS EN EL TRANSPORTE NÚCLEO-CITOPLASMA.

Investigador Principal: ESTHER ROSELLÓ LLETÍ

PI14/01506 . INSTITUTO DE SALUD CARLOS III . 2015

DIAGNÓSTICO GENÉTICO MOLECULAR DE LA AMAUROSIS CONGÉNITA DE LEBER MEDIANTE SECUENCIACIÓN MASIVA DE NUEVA GENERACIÓN (NGS).

Investigador Principal: ELENA MARÍA ALLER MAÑAS

2015_0103_CRC_ALLER . FUNDACION MUTUA MADRILEÑA . 2015

GENÓMICA, ESTUDIOS PRECLÍNICOS Y CLÍNICOS PARA UNA MEDICINA DE PRECISIÓN EN DISTROFIAS HEREDITARIAS DE LA RETINA: EL SÍNDROME DE USHER.

Investigador Principal: JOSÉ MARÍA MILLÁN SALVADOR

PI16/00539 . INSTITUTO DE SALUD CARLOS III . 2017

Desarrollo de nanoterapias anti-inflamatorias en retinosis pigmentaria.

Investigador Principal: REGINA RODRIGO NICOLÁS

PI18/00252 . INSTITUTO DE SALUD CARLOS III . 2019

Estudio de mutaciones ocultas en pacientes con sindrome de Usher.

Investigador Principal: JOSÉ MARÍA MILLÁN SALVADOR

2018_0675_CRC_MILLAN . FUNDACION ONCE . 2018

Tu hospital investiga RRI.

Investigador Principal: ANA ISABEL JUAN ROCH

FCT-18-14018 . FUNDACION ESPAÑOLA PARA LA CIENCIA Y LA TECNOLOGIA . 2019

Compartir la publicació